#hepatocellular carcinoma

From 1992 to 2018, liver cancer cases related to hepatitis C fell in Japan.

Use of cholesterol-lowering medications was also associated with reduced mortality from liver cancer and other causes.

An advisory panel reviewed follow-up data on checkpoint inhibitors, voting to maintain four approvals and rescind two.

In a small study, 80% of participants treated with Cabometyx and Opdivo underwent successful surgery.

People treated with direct-acting antivirals had better overall survival than those whose hepatitis C remained untreated.

But a simple improvement in dietary intake reversed fatty liver disease and staved off cancer.

Sintilimab plus chemotherapy infused into a liver artery may offer the chance for a cure.

Disruptions in access to treatment and harm reduction services could set back effort to eliminate hep C in the U.S.

Coffee drinkers appear to have a 49% lower risk of dying of chronic liver disease.

Suppression of hepatitis B virus with antiviral treatment lowered the risk of hepatocellular carcinoma by 58%.

People with NAFLD have an elevated risk of cancer, largely due to high liver cancer incidence.

Weight-loss surgery especially reduced obesity-related cancers in people with liver cirrhosis.

People living with both viruses remain at risk for hepatocellular carcinoma despite antiviral therapy.

Mice that performed modest exercise were less likely to show signs of inflammation, cell aging and liver cancer.

Blue Faery’s “Love Your Liver” 28-day video campaign raises awareness of liver cancer and overall liver health.

Compared to other racial and ethnic groups, Blacks are also less likely to be diagnosed early.